Bring reproductive health genetic testing in-house 

Clinical testing solutions

What is preimplantation genetic testing (PGT)?

Preimplantation genetic testing screens for genetic events in embryos as a result of in vitro fertilisation procedures (IVF). PGT-aneuploidy (PGT-A) is used to analyse the number of chromosomes, PGT-SR, the structure rearrangement of each chromosome, and PGT-monogenic (PGT-M), the presence of genetic mutations in single gene, potentially linked to a disorder. All PGT methods are used to determine the suitability of an embryo for implantation.

Discover our workflow

Prepare your embryo

Analyse your embryo biopsy

Ion Reporter Software Aneuploidy Dx Workflows

The Ion Reporter Software Aneuploidy Dx Workflows is the first brought‑to‑market, CE‑marked IVDD preimplantation genetic analysis solution of aneuploidies in embryos prior to transfer to the uterus of women undergoing in vitro fertilisation.

Plan your readiness and apply our CE-marked IVD solution for analysis of aneuploidies in embryos.

Intended use

Ion Reporter Software (IR) Aneuploidy Dx Workflows (Low-pass whole-genome aneuploidy Dx w1.0 / Low-pass whole-genome aneuploidy Mosaic Dx w1.0) constitute an in vitro diagnostic medical device intended to be used by professionally trained personnel for the qualitative determination of aneuploidies, including the trisomy status of chromosome 21, in genomic DNA derived from human cells using next generation sequencing (NGS). The detection of aneuploidies is intended for screening to be used as preimplantation genomic analysis on biopsies from embryos prior to transfer to the uterus of women undergoing in vitro fertilisation.

Resources